Amicus Therapeutics Inc. buy Cantor Fitzgerald
Start price
07.11.24
/
50%
€10.00
Target price
07.11.25
€19.47
Performance (%)
-42.50%
Price
08.08.25
€5.75
Summary
This prediction is currently active. The BUY prediction by Cantor_Fitzgerald for Amicus Therapeutics Inc. is performing very badly with a performance of -42.50%. This prediction currently runs until 07.11.25. The prediction end date can be changed by Cantor_Fitzgerald at any time. Cantor_Fitzgerald has 50% into this predictionPerformance without dividends (%)
| Name | 1w | 1m |
|---|---|---|
| Amicus Therapeutics Inc. | 5.505% | 5.505% |
| iShares Core DAX® | 1.217% | -0.632% |
| iShares Nasdaq 100 | 1.220% | 4.085% |
| iShares Nikkei 225® | 3.599% | 7.023% |
| iShares S&P 500 | 0.462% | 2.682% |
Comments by Cantor_Fitzgerald for this prediction
In the thread Amicus Therapeutics Inc. diskutieren
Amicus Therapeutics, Inc. (NASDAQ: FOLD) had its price target raised by analysts at Cantor Fitzgerald from $20.00 to $21.00. They now have an "overweight" rating on the stock.
Ratings data for FOLD provided by MarketBeat
Stopped prediction by Cantor_Fitzgerald for Amicus Therapeutics Inc.
Amicus Therapeutics Inc.
Start price
Target price
Perf. (%)
€9.00
15.01.25
15.01.25
€20.29
15.01.26
15.01.26
-36.11%
08.08.25
08.08.25
Amicus Therapeutics Inc.
Start price
Target price
Perf. (%)
€10.00
20.09.24
20.09.24
€17.90
20.09.25
20.09.25
-42.50%
08.08.25
08.08.25
Amicus Therapeutics Inc.
Start price
Target price
Perf. (%)
€11.80
29.02.24
29.02.24
€20.36
28.02.25
28.02.25
-24.15%
01.03.25
01.03.25